Application Nr Approved Date Route Status External Links
ANDA210992 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Methylphenidate Hydrochloride Extended-Release Tablets Are Indicated For The Treatment Of: Attention Deficit Hyperactivity Disorders (Adhd) In Pediatric Patients 6 Years And Older And Adults Narcolepsy Methylphenidate Hydrochloride Extended-Release Tablet Is A Central Nervous System (Cns) Stimulant Indicated For The Treatment Of Attention Deficit Hyperactivity Disorders (Adhd) And Narcolepsy

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Methylphenidate Hydrochloride METHYLPHENIDATE HYDROCHLORIDE ZINC2522648

Comments